<i>Medical Insiders:</i> Current Practices in AF Management: Are Guideline-Based Options Driving Better Outcomes?
Webcast Webcast

Medical Insiders: Current Practices in AF Management: Are Guideline-Based Options Driving Better Outcomes?


Released:
11/12/19
Expires:
11/11/20
PDF:

Maximum Credits:

0.5
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Webcast Webcast
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
11/12/19

Expires:
11/11/20

PDF:

Maximum Credits:
0.5
Webcast Webcast
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
11/12/19
Expires:
11/11/20
PDF:


Maximum Credits:
0.5


Overview: This 30-minute Medical Insiders accredited CME webcast features expert cardiologists Gerald V. Naccarelli, MD, and James A. Reiffel, MD, and electrophysiologist E. Magnus Ohman, MD, FRCPI, FESC, FACC, FSCAI. These faculty provide insight on specific challenges clinicians face when managing patients with atrial fibrillation (AF) and discuss best practices in developing individualized treatment plans to prevent AF progression, reduce hospitalizations, and decrease the risks of morbidity and mortality.

CME Information:

Presenter
Gerald V. Naccarelli, MD
Bernard Trabin Chair in Cardiology
Professor of Medicine
Chief, Division of Cardiology
Pennsylvania State University College of Medicine
The Milton S. Hershey Medical Center
Hershey, PA

E. Magnus Ohman, MD, FRCPI, FESC, FACC, FSCAI
Professor of Medicine
The Kent and Siri Rawson Director, Duke Program for Advanced Coronary Disease
Vice-Chair, Department of Medicine - Development and Innovation
Associate Director, Duke Heart Center
Senior Investigator, Duke Clinical Research Institute
Duke University Medical Center
Durham, NC

Professor (Emeritus) of Medicine and Special Lecturer
Columbia University Vagelos College of Physicians and Surgeons
Department of Medicine, Division of Cardiology, Electrophysiology Section
New York, NY

Activity Planners
Iwona Misiuta, PhD, MHA
Clinical Content Manager
Med-IQ
Baltimore, MD
 
Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD
 
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
Med-IQ
East Lansing, MI

Learning Objectives
Upon completion, participants should be able to:
  • Identify criteria and tools to facilitate the assessment of ongoing AF symptoms and patients’ quality of life
  • Select appropriate individualized treatments for patients with AF based on disease- and patient-related factors
Target Audience
This activity is intended for cardiologists and electrophysiologists. 
 
Statement of Need
AF affects between 3 and 6 million Americans—a number that is expected to increase to 12.1 million by 2030—and is associated with increased morbidity and mortality and reduced quality of life. Evolving information has helped better characterize the complexity of AF management and highlight the need for highly individualized treatment. However, despite increasingly detailed and recently updated guidance on the management of this heterogeneous patient population, registry data demonstrate ample opportunities for continued improvement in AF-related morbidity, mortality, and healthcare utilization, as well as patient quality of life. Furthermore, a vast body of clinical trial data does not definitively answer many questions about the choice between a rate- or rhythm-control strategy or medical versus interventional approaches to restoring sinus rhythm. Therefore, individualizing treatment plans based on patient- and disease-related factors is critical in ensuring optimal patient outcomes and preventing AF symptom recurrence and disease progression. 
 
Providership Statement
Provided by Med-IQ.

Accreditation/Designation Statement
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med-IQ designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Instructions to Receive Credit
To receive credit, read the introductory CME material, watch the webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly. 

Initial Release Date: November 12, 2019
Expiration Date: November 11, 2020
Estimated Time to Complete This Activity: 30 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.

Gerald V. Naccarelli, MD
Consulting fees/advisory boards: Ascension, OMEICOS Therapeutics, Janssen Pharmaceuticals, Inc., Milestone Pharmaceuticals, Inc.
Contracted research: Janssen Pharmaceuticals, Inc.

E. Magnus Ohman, MD, FRCPI, FESC, FACC, FSCAI
Consulting fees/advisory boards: 3D Communication, Abiomed, ACI Clinical, Acorda Therapeutics, Cara Therapeutics, Cardinal Health, Faculty Connection, Imbria Pharmaceuticals, Impulse Medical Technologies, Janssen Pharmaceuticals, Inc., Milestone Pharmaceuticals, Inc., XyloCor Therapeutics
Contracted research: Abiomed, Chiesi USA, Portola Pharmaceuticals

James A. Reiffel, MD
Consulting fees/advisory boards: Ascension, Janssen Pharmaceuticals, Inc.
Fees received for promotional/non-CME activities: Janssen Pharmaceuticals, Inc.
Contracted research: Janssen Pharmaceuticals, Inc., Medtronic, Inc.

The peer reviewers and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
 
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information        
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.

System Requirements
Desktop
Mobile
  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)
Applications & Software
For technical assistance, please refer to our Support Manual.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy policy, please visit: www.med-iq.com/privacy-policy.html.

Acknowledgement of Commercial Support
This activity is supported by an educational grant from Sanofi US.

Copyright
© 2019 Med-IQ, Inc.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.

We recently updated our Privacy Notice and Terms of Use.